For the first time, we demonstrated that an AET program can up-regulate the antiatherogenic eNOS-NO and nNOS-H2O2 pathways, which is associated with amelioration of endothelial function in a genetic model of hypercholesterolemia. This evidence concerns the gene NOS1 and familial hypercholesterolemia.